Text Size

Inhaled Mannitol and Ciliary Beat Frequency in COPD Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2007 by Imperial College London.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Imperial College London
ClinicalTrials.gov Identifier:
NCT00446121
First received: March 9, 2007
Last updated: NA
Last verified: March 2007
History: No changes posted
  Purpose

The main purpose of the study is to evaluate the effect of mannitol on the cilia's beat frequency (ciliary beat frequency) in COPD patients.


Condition
Chronic Obstructive Pulmonary Disease

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: The Effect of Inhaled Mannitol on Ciliary Beat Frequency in COPD Patients

Resource links provided by NLM:

Drug Information available for: Mannitol
U.S. FDA Resources

Further study details as provided by Imperial College London:

  Eligibility

Ages Eligible for Study:   38 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • COPD
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00446121

Contacts
Contact: Sergei Kharitonov, MD PhD +44 02073518051 s.kharitonov@imperial.ac.uk
Contact: Lars Pedersen, MD +44 02073518051 l.pedersen@imperial.ac.uk

Locations
United Kingdom
Airway Disease Section, Asthma Lab, Imperial College London, Royal Brompton Hospital Recruiting
London, United Kingdom, SW3 6LY
Contact: Sergei Kharitonov, MD PhD     +44 02073518051     s.kharitonov@imperial.ac.uk    
Contact: Lars Pedersen, MD     +44 02073518051     l.pedersen@imperial.ac.uk    
Principal Investigator: Sergei Kharitonov, MD PhD            
Sub-Investigator: Lars Pedersen, MD            
Sub-Investigator: Peter J Barnes, MA DM DSc FRCP            
Sponsors and Collaborators
Imperial College London
Investigators
Principal Investigator: Sergei Kharitonov, MD PhD Imperial College London
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00446121     History of Changes
Other Study ID Numbers: 06/Q0410/55
Study First Received: March 9, 2007
Last Updated: March 9, 2007
Health Authority: United Kingdom: Research Ethics Committee

Keywords provided by Imperial College London:
COPD

Additional relevant MeSH terms:
Lung Diseases
Respiration Disorders
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Respiratory Tract Diseases
Mannitol
Diuretics, Osmotic
 Diuretics
Natriuretic Agents
Physiological Effects of Drugs
Pharmacologic Actions
Cardiovascular Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on June 13, 2013